Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Emily C Ayers"'
Autor:
Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Qualls, Behzad Amoozgar, Brad Kahl, John Baird, Pavan Challa, Scott F Huntington, Jennifer Santos, Steven Bair, Mayur Narkhede, Shuning Li, Zachary Frosch, Carrie Ho, Stephen D Smith, Allison Winter, Daniel Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Mwanasha Merril, Jennifer L. Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla, Emily C Ayers
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) are poor. Loncastuximab-teserine (Lonca) is an antibody drug conjugate (ADC) which was FDA approved for R/R DLBCL patients who have received at least 2 prior li
Externí odkaz:
https://doaj.org/article/28e5c35c2c204cf6bb7601f5c351589e
Autor:
Emily C. Ayers, Sunita D. Nasta
Publikováno v:
European Medical Journal, Vol 3, Iss 4, Pp 40-48 (2018)
Immunotherapy has revolutionised the treatment of haematologic malignancies. Patients with relapsed/refractory non-Hodgkin’s lymphoma have poor response rates and short survival times when conventional cytotoxic chemotherapies are used. Immunothera
Externí odkaz:
https://doaj.org/article/fe39e6ded04d46c7a5d0508775c1e3d6
Autor:
Brian T. Hess, Anshu Giri, Yeonhee Park, Krina K. Patel, Brian K. Link, Grzegorz S. Nowakowski, Seth M. Maliske, Sonia Fortin, Julio C. Chavez, Hayder Saeed, Brian T. Hill, Alex V. Mejia Garcia, Kami J. Maddocks, Walter Hanel, Nina D. Wagner‐Johnston, Marcus R. Messmer, Brad S. Kahl, Marcus Watkins, Juan Pablo Alderuccio, Izidore S. Lossos, Sunita Nathan, Victor M. Orellana‐Noia, Craig A. Portell, Daniel J. Landsburg, Emily C. Ayers, Jorge J. Castillo
Publikováno v:
American Journal of Hematology. 98:300-308
Plasmablastic lymphoma (PBL) is a rare entity, commonly associated with immunosuppressed states such as human immunodeficiency virus (HIV) infection or solid organ transplant. The clinical course is characterized by high relapse rates and a poor prog
Autor:
Adam Stephen Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Ryan Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin H. Karimi, Narendranath Epperla, David A Bond, Umar Farooq, Mahak Saad, Andrew M Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley M Haverkos, Reem Karmali, Timothy S Oh, Julie M Vose, Heather R Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J Olszewski
Publikováno v:
Blood Advances.
In this multi-institutional retrospective study, we examined characteristics and outcomes of 160 patients with high-grade B-cell lymphoma, not otherwise specified (HGBL-NOS). This rare lymphoma category is defined by high-grade morphologic features,
Autor:
Narendranath Epperla, Adam Zayac, Daniel J. Landsburg, Mitchell Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin Karimi, David A. Bond, Umar Farooq, Mahak Saad, Andrew Matthew Evens, Karan Pandya, Seema G Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Timothy S Oh, Julie M. Vose, Heather Nutsch, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Publikováno v:
Blood. 140:3839-3841
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Publikováno v:
Blood Reviews. :101101
Autor:
Nathan Roberts, John Lister, N. Nora Bennani, Salvia Jain, Tammy Battaglia, Emily C. Ayers, Craig A. Portell, Michael E. Williams, Prem Batchala, Ipsita Pal, Owen A. O'Connor, John Sanil Manavalan, Enrica Marchi
Publikováno v:
Blood. 140:9425-9426
Autor:
Adam J. Olszewski, Brad S. Kahl, Christopher Del Prete, Thomas A Ollila, Victor M. Orellana-Noia, Craig A. Portell, Jun Lee, A. Mccook, Hanan Alharthy, Benjamin Echalier, Paolo F. Caimi, Natalie S Grover, Hayder Saeed, Daniel J. Landsburg, Ajay Major, Alexandra E Rojek, Jieqi Liu, Timothy Fu, Ranjana H. Advani, Yuxin Liu, Manali Kamdar, Stephen E. Spurgeon, Harsh Shah, Daniel R Reed, Emily C. Ayers, Jennie Y. Law, Jeremy M Sen, Jonathon B. Cohen, Jeffrey M. Switchenko, Reem Karmali, Scott F. Huntington, Timothy J Voorhees, Anson Snow, Julio C. Chavez, Frederick Lansigan, Jason T. Romancik, Mary-Kate Malecek, Brain T Hill, Christian M Barlow, Amy A. Ayers, Amulya Yellala, Mohammad Ahsan Sohail, Nadia Khan, Aleksandr Lazaryan, Deborah M. Stephens, Marcus P Watkins, Michael A. Spinner, Shazia Nakhoda, Kevin A. David, Avyakta Kallam, Odeth Barrett-Campbell, Vikram Raghunathan, Sonali M. Smith
Publikováno v:
Blood
Prophylaxis is commonly used to prevent central nervous sy stem (CNS) relapse in diffuse large B-cell lymphoma (DLBCL), with no clear standard of care. We retrospectively evaluated 1162 adult patients across 21 US academic centers with DLBCL or simil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6766d28bba0053ec72908d58e3a0859
https://europepmc.org/articles/PMC8777199/
https://europepmc.org/articles/PMC8777199/
Publikováno v:
Cancer Drug Discovery and Development ISBN: 9783030878481
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b785040b3697f715089ea63a2e0d63e
https://doi.org/10.1007/978-3-030-87849-8_11
https://doi.org/10.1007/978-3-030-87849-8_11
Autor:
David A. Bond, Angel Mier Hicks, Amir Behdad, Pallawi Torka, Daniel J. Landsburg, Nina D. Wagner-Johnston, Julio C. Chavez, Kami J. Maddocks, Reem Karmali, Rawan Faramand, Radhakrishnan Ramchandren, Emily C. Ayers, Madeira Curry, Dipenkumar Modi, L. Jeffrey Medeiros, Sarit Assouline, Shaoying Li
Publikováno v:
British Journal of Haematology. 189:313-317
While patients with double-hit lymphoma (DHL) are now frequently treated with intensive front-line immunochemotherapy, outcomes for those who fail these regimens and subsequently receive curative-intent second-line immunochemotherapy are unknown. We